Phase III trials of coronavirus vaccine to take place at 5 US military sites, Pentagon confirms
The five sites will test AZD1222, the vaccine candidate currently being developed by AstraZeneca.
Phase III trials of coronavirus vaccine to take place at 5 US military sites, Pentagon confirms
The five sites will test AZD1222, the vaccine candidate currently being developed by AstraZeneca.